Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.
Sub-Sectors in Focus
Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.
- Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
- Healthcare delivery - hospitals, diagnostics, single specialty
- Medical technology - lifesciences, medical devices, consumables
Led By
Chintan Kothari
Executive Director and Head, Healthcare, Avendus Capital
Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.
He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.
Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.
Transactions
.jpg){kind=spacer}
Reports
Hot and Spicy | INR 50,000 Cr Branded Spices Market
Branded Spices is the most attractive segment within the food space, due to its large market size, high growth and robust material margins. Take a deep dive into the category, see what drives valuation in this sector and uncover emerging trends that are driving growth.
Future Leaders in Used Commercial Vehicle Finance
An emerging breed of asset financiers focused on used vehicles have gained traction in the last 5–10 years. Our thought paper sheds light on these regional NBFCs that have captured investor interest.
Low Code Software and Services Providers Landscape
Low code software platforms are empowering professionals with little to no coding expertise to develop applications. Gartner predicts that 75% of large enterprises will be using at least 4 low code tools by 2024. Our thought paper delves into this industry which is set to grow at a 28% CAGR in 5 years.
Digital & Technology | 2021: The Breakout Year
2020 has been the year of structural shift for the digital economy, primarily due to COVID. While the real economy suffered, digital enabled economy got a booster shot. Our annual thought paper sets our predictions for 2021 to be the break-out year for the Indian Digital and Tech ecosystem, with the momentum in the funding environment likely to accelerate – We expect US$20bn+ funding in the private markets.
D2C Brands: Disrupting the next decade of shopping
Consumption patterns in India are evolving. With rise in online shopping and spurred by the opportunity to capitalize on white spaces and a more demanding consumer, new-age brands are emerging. Eyeing a $100bn addressable market by 2025, direct-to-customer brands are set to disrupt the way India shops in the coming decade.
Indian Specialty Chemicals Industry - Biggest Beneficiary of the Global Paradigm Shift
Avendus in collaboration with FICCI, has developed this report in order to highlight the emerging opportunity for the Indian Specialty Chemicals industry, which is estimated to double in size by 2025.